Click here to access the Swedish Press Library 🇸🇪 Press contact:Cecilia Edströmcecilia.edstrom@a3p.com+46 72 226 2328 Caj Westlund 07/11/2024 Caj Westlund 07/11/2024 Strategic partnership for Stockholm3 in Switzerland Read More Caj Westlund 23/08/2024 Caj Westlund 23/08/2024 Stockholm3 independently validated at the world-renowned Martini Klinik Read More Caj Westlund 24/07/2024 Caj Westlund 24/07/2024 Landmark Stockholm3 multi-ethnical trial published in top-ranked Journal of Clinical Oncology Read More Caj Westlund 03/07/2024 Caj Westlund 03/07/2024 Stockholm 3 commercially available in the USA Read More Caj Westlund 26/06/2024 Caj Westlund 26/06/2024 Stockholm3 reduces prostate cancer treatment costs and enhances diagnostic precision Read More Caj Westlund 31/05/2024 Caj Westlund 31/05/2024 Leadership changes at A3P Biomedical Read More Caj Westlund 22/04/2024 Caj Westlund 22/04/2024 Stockholm3 study awarded best abstract in the prostate cancer biopsy indication session at the 2024 European Association of Urology meeting Read More Caj Westlund 20/02/2024 Caj Westlund 20/02/2024 Stockholm3 evaluated for Swedish screening program Read More Caj Westlund 13/02/2024 Caj Westlund 13/02/2024 Stockholm3 leads to earlier detection of prostate cancer, improved precision, and better health economics Read More Caj Westlund 29/01/2024 Caj Westlund 29/01/2024 Landmark Stockholm3 North American clinical trial presented at ASCO-GU Read More Caj Westlund 13/09/2023 Caj Westlund 13/09/2023 A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA Read More Caj Westlund 31/08/2023 Caj Westlund 31/08/2023 Stockholm3 combines accurate diagnosis of prostate cancer with improved health economics Read More Caj Westlund 04/05/2023 Caj Westlund 04/05/2023 Stockholm3 included in the American Urological Association (AUA) guidelines for early detection of prostate cancer Read More Caj Westlund 20/03/2023 Caj Westlund 20/03/2023 Stockholm3 study awarded as one of the best abstracts of the 2023 annual European Association of Urology meeting Read More Caj Westlund 10/02/2023 Caj Westlund 10/02/2023 New Stockholm3 data accepted for presentation at the upcoming European Association of Urology meeting Read More Caj Westlund 01/02/2023 Caj Westlund 01/02/2023 Groves Medical Group starts offering Stockholm3 in the UK Read More Caj Westlund 12/01/2023 Caj Westlund 12/01/2023 Clinical study validates that Stockholm3 provides significantly higher clinical benefit than European prostate cancer risk calculator Read More Caj Westlund 01/11/2022 Caj Westlund 01/11/2022 A3P Biomedical appoints Andreas Hoel as new VP of Marketing & Sales Read More Caj Westlund 31/10/2022 Caj Westlund 31/10/2022 Zürich University Hospital starts using Stockholm3 Read More Caj Westlund 26/09/2022 Caj Westlund 26/09/2022 The European Commission recommends member states to implement organized screening of prostate cancer Read More Older Posts
Caj Westlund 07/11/2024 Caj Westlund 07/11/2024 Strategic partnership for Stockholm3 in Switzerland Read More
Caj Westlund 23/08/2024 Caj Westlund 23/08/2024 Stockholm3 independently validated at the world-renowned Martini Klinik Read More
Caj Westlund 24/07/2024 Caj Westlund 24/07/2024 Landmark Stockholm3 multi-ethnical trial published in top-ranked Journal of Clinical Oncology Read More
Caj Westlund 03/07/2024 Caj Westlund 03/07/2024 Stockholm 3 commercially available in the USA Read More
Caj Westlund 26/06/2024 Caj Westlund 26/06/2024 Stockholm3 reduces prostate cancer treatment costs and enhances diagnostic precision Read More
Caj Westlund 22/04/2024 Caj Westlund 22/04/2024 Stockholm3 study awarded best abstract in the prostate cancer biopsy indication session at the 2024 European Association of Urology meeting Read More
Caj Westlund 20/02/2024 Caj Westlund 20/02/2024 Stockholm3 evaluated for Swedish screening program Read More
Caj Westlund 13/02/2024 Caj Westlund 13/02/2024 Stockholm3 leads to earlier detection of prostate cancer, improved precision, and better health economics Read More
Caj Westlund 29/01/2024 Caj Westlund 29/01/2024 Landmark Stockholm3 North American clinical trial presented at ASCO-GU Read More
Caj Westlund 13/09/2023 Caj Westlund 13/09/2023 A3P Biomedical and BioAgilytix enter partnership for Stockholm3 in the USA Read More
Caj Westlund 31/08/2023 Caj Westlund 31/08/2023 Stockholm3 combines accurate diagnosis of prostate cancer with improved health economics Read More
Caj Westlund 04/05/2023 Caj Westlund 04/05/2023 Stockholm3 included in the American Urological Association (AUA) guidelines for early detection of prostate cancer Read More
Caj Westlund 20/03/2023 Caj Westlund 20/03/2023 Stockholm3 study awarded as one of the best abstracts of the 2023 annual European Association of Urology meeting Read More
Caj Westlund 10/02/2023 Caj Westlund 10/02/2023 New Stockholm3 data accepted for presentation at the upcoming European Association of Urology meeting Read More
Caj Westlund 01/02/2023 Caj Westlund 01/02/2023 Groves Medical Group starts offering Stockholm3 in the UK Read More
Caj Westlund 12/01/2023 Caj Westlund 12/01/2023 Clinical study validates that Stockholm3 provides significantly higher clinical benefit than European prostate cancer risk calculator Read More
Caj Westlund 01/11/2022 Caj Westlund 01/11/2022 A3P Biomedical appoints Andreas Hoel as new VP of Marketing & Sales Read More
Caj Westlund 31/10/2022 Caj Westlund 31/10/2022 Zürich University Hospital starts using Stockholm3 Read More
Caj Westlund 26/09/2022 Caj Westlund 26/09/2022 The European Commission recommends member states to implement organized screening of prostate cancer Read More
